Case report
Patient 1. A 19-year-old woman presented with drug-resistant myoclonus that had persisted for 18 years. Her birth was uneventful. A febrile seizure occurred at 9 months of age, followed by a non-febrile seizure 5 months later. She was given a diagnosis of epilepsy based on electroencephalographic abnormalities, and was administered with valproic acid (VPA). At the same time, she was pointed out to have tremulous myoclonus of extremities diagnosed by surface electromyography (SEMG) findings of 100-msec muscle discharges that were synchronized between antagonistic muscles. Stimulating the median nerve for somatosensory evoked potentials (SEP) showed normal amplitude. Seizures were controlled by VPA (200) mg and levetiracetam (2000 mg) but the myoclonus persisted. At the time of presentation, she had facial tics, myoclonus of all limbs, chorea of the fingers, and limb ataxia. Adding clonazepam (CZP; 1 mg) somewhat relieved the myoclonus (Video S1). SMEG showed synchronization between the left extensor carpi radialis and left flexor carpi ulnaris muscles with a duration of 100-150 msec (Fig. 1A) . She was initially started on PER (2 mg/day), then the dose was increased to 4 mg/day two months later, and this much improved the myoclonus (Video S2). (Fig. 1Β, right) .
Discussion
Low doses of PER (2-6 mg/day) are effective against intractable myoclonus in patients with Lance-Adams syndrome, UnverrichtLundborg disease (ULD), postsurgical cortical myoclonus and Lafora disease [2] [3] [4] [5] [6] [7] [8] . Oi et al. [8] reported decreased of giant SEP amplitude and prolonged latencies (P25 and N33), and the correlation with the degree of ADL improvement and PER concentration for patients with refractory cortical myoclonus after PEM administration. The generator of P25 and N33 arise from the crown of the postcentral gyrus, and P25 was partly located in the motor and sensory areas. In the patient 2, the improvement of myoclonus and the reduction in the SEP expansion amplitude after PEM administration were presumed to be due to the suppression of abnormal cortical hyperexcitability in the primary sensorimotor cortex.
Myoclonus originating in the cortex can be associated with various epilepsy syndromes, but it could also be a subcortical phenomenon associated with post-hypoxic brain damage as in Lance-Adams syn- 
